进行性肌阵挛共济失调近亲家系全外显子测序漏诊原因分析与对策

doi:10.16150/j.1671-2870.2022.04.007

摘要/Abstract

摘要：

目的：分析近亲家系全外显子测序（whole exome sequencing, WES）中漏诊5例进行性肌阵挛共济失调（progressive myoclonic ataxia, PMA）患者的原因,并探讨对策。方法：收集5例WES未发现致病突变而临床拟诊为PMA患者,对其近亲婚配家系（三代以内旁系血亲婚配）进行全基因组SNP芯片扫描,通过纯合子定位技术及单倍型分析定位致病区间,结合患者的肌阵挛和共济失调表型,明确其可能的致病基因。采用Sanger测序对候选的突变位点进行家系共分离分析,最后通过溯源WES比对过程中的SAM与BAM文件,分析WES漏诊的原因。结果：纯合区间定位和重分析WES发现,5例PMA家系为NEU1基因c. 544A>G（p.S182G）纯合突变导致的Ⅰ型唾液酸沉积症（sialidosis type Ⅰ, ST-Ⅰ）。人类基因组参考序列中的ALT contig在WES比对过程中可造成包括NEU1基因在内的多个PMA致病基因检出遗漏。结论：临床诊断中,常染色体隐性遗传的PMA需关注NEU1基因突变所导致的ST-Ⅰ。对于WES未发现致病位点的PMA家系,可结合家系遗传方式、全基因组SNP芯片等方法定位致病区间,再结合患者的临床表型以明确其疾病致病基因。

关键词: 进行性肌阵挛共济失调, Ⅰ型唾液酸沉积症, 全外显子测序, NEU1基因

Abstract:

Objective: To investigate the causes and strategies of missed diagnosis of progressive myoclonic ataxia (PMA) consanguineous families by whole exome sequencing (WES). Methods: Five PMA consanguineous families with no disease causative variants detected by WES were enrolled, and homozygosity mapping and haplotype analysis for locating disease related region were performed. Further combined with myoclonus and ataxia phenotypes, the possible pathogenic genes were identified. Sanger sequencing was used to verify the candidate mutation and perfomed family co-segregation in five families. Finally, the reasons for missed diagnosis were analyzed by tracing to the SAM and BAM files from WES alignment process. Results: By homozygous regional mapping and reanalysis of WES, 5 families with progressive myoclonic ataxia were identified as sialidosis type I (ST-I) caused by homozygous mutation of NEU1 gene c.544A >G(p.S182G). It was also found that ALT contig in human genome reference sequence could cause multiple pathogenic genes including NEU1 gene to be missed during WES alignment. Conclusions: In clinical diagnosis, autosomal recessive PMA should be paid attention to ST-I which caused by NEU1 gene mutation. For families with hereditary diseases in which WES has not found pathogenic loci, the pathogenic region can be located by combining family genetic mode and genome-wide SNP chip, then the pathogenic genes can be identified by clinical manifestations analysis.

Key words: Progressive myoclonic ataxia, Sialidosis type Ⅰ, Whole exome sequencing, NEU1 gene

中图分类号:

R541.7

杨慧, 李云璐, 杨康, 李世举, 何瑾. 进行性肌阵挛共济失调近亲家系全外显子测序漏诊原因分析与对策[J]. 诊断学理论与实践, 2022, 21(04): 456-461.

YANG Hui, LI Yunlu, YANG Kang, LI Shiju, HE Jin. Misdiagnosis by whole exome sequencing in progressive myoclonic ataxia consanguineous families: causes and strategies[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 456-461.

图/表 3

图1

表1

图2

参考文献 19

[1]	Muona M, Berkovic SF, Dibbens LM, et al. A recurrent de novo mutation in KCNC1 causes progressive myo-clonus epilepsy[J]. Nat Genet, 2015, 47(1):39-46. doi: 10.1038/ng.3144
[2]	Marseille Consensus Group. Classification of progressive myoclonus epilepsies and related disorders[J]. Ann Neurol, 1990, 28(1):113-116. doi: 10.1002/ana.410280129 URL
[3]	van der Veen S, Zutt R, Elting JWJ, et al. Progressive myoclonus ataxia: time for a new definition?[J]. Mov Disord, 2018, 33(8):1281-1286. doi: 10.1002/mds.27412 URL
[4]	Rossi M, van der Veen S, Merello M, et al. Myoclonu-sataxia syndromes: a diagnostic approach[J]. Mov Disord Clin Pract, 2020, 8(1):9-24. doi: 10.1002/mdc3.13106 URL
[5]	Kherraf ZE, Cazin C, Bouker A, et al. Whole-exome sequencing improves the diagnosis and care of men with non-obstructive azoospermia[J]. Am J Hum Genet, 2022, 109(3):508-517. doi: 10.1016/j.ajhg.2022.01.011 URL
[6]	Gabriel H, Korinth D, Ritthaler M, et al. Trio exome sequencing is highly relevant in prenatal diagnostics[J]. Prenat Diagn, 2022, 42(7):845-851. doi: 10.1002/pd.6081 URL
[7]	Alkuraya FS. Discovery of rare homozygous mutations from studies of consanguineous pedigrees[J]. Curr Protoc Hum Genet, 2012,Chapter 6:Unit6.12.
[8]	Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses[J]. Am J Hum Genet, 2007, 81(3):559-575. doi: 10.1086/519795 pmid: 17701901
[9]	Hamilton A, Tétreault M, Dyment DA, et al. Concordance between whole-exome sequencing and clinical Sanger sequencing: implications for patient care[J]. Mol Genet Genomic Med, 2016, 4(5):504-512. doi: 10.1002/mgg3.223 URL
[10]	Goodwin S, McPherson JD, McCombie WR. Coming of age: ten years of next-generation sequencing technologies[J]. Nat Rev Genet, 2016, 17(6):333-351. doi: 10.1038/nrg.2016.49 pmid: 27184599
[11]	Ma X, Shao Y, Tian L, et al. Analysis of error profiles in deep next-generation sequencing data[J]. Genome Biol, 2019, 20(1):50. doi: 10.1186/s13059-019-1659-6 pmid: 30867008
[12]	Ross MG, Russ C, Costello M, et al. Characterizing and measuring bias in sequence data[J]. Genome Biol, 2013, 14(5):R51. doi: 10.1186/gb-2013-14-5-r51 URL
[13]	Lelieveld SH, Spielmann M, Mundlos S, et al. Comparison of exome and genome sequencing technologies for the complete capture of protein-coding regions[J]. Hum Mutat, 2015, 36(8):815-822. doi: 10.1002/humu.22813 pmid: 25973577
[14]	Kong SW, Lee IH, Liu X, et al. Measuring coverage and accuracy of whole-exome sequencing in clinical context[J]. Genet Med, 2018, 20(12):1617-1626. doi: 10.1038/gim.2018.51 pmid: 29789557
[15]	Reis CS, Quental S, Fernandes S, et al. Whole-exome sequencing targeting a gene panel for sensorineural hearing loss: the first portuguese cohort study[J]. Cytogenet Genome Res, 2022, 162(1-2):1-9. doi: 10.1159/000523840 URL
[16]	Haarman AEG, Thiadens AAHJ, van Tienhoven M, et al. Whole exome sequencing of known eye genes reveals genetic causes for high myopia[J/OL]. Hum Mol Genet, 2022[2022-08-23]. https://pubmed.ncbi.nlm.nih.gov/35567543/.
[17]	Sreenivasan R, Bell K, van den Bergen J, et al. Whole exome sequencing reveals copy number variants in individuals with disorders of sex development[J]. Mol Cell Endocrinol, 2022, 546:111570. doi: 10.1016/j.mce.2022.111570 URL
[18]	Mandelker D, Schmidt RJ, Ankala A, et al. Navigating highly homologous genes in a molecular diagnostic setting: a resource for clinical next-generation sequencing[J]. Genet Med, 2016, 18(12):1282-1289. doi: 10.1038/gim.2016.58 pmid: 27228465
[19]	Cao YN, Li L, Xu M, et al. The ChinaMAP analytics of deep whole genome sequences in 10 588 individuals[J]. Cell Res, 2020, 30(9):717-731. doi: 10.1038/s41422-020-0322-9 URL